BIOMAT Database Logo BIOMAT Database Logo

Radiologically isolated syndrome should be treated with disease-modifying therapy - Commentary. 2017

Christine Lebrun

UI MeSH Term Description Entries
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013577 Syndrome A characteristic symptom complex. Symptom Cluster,Cluster, Symptom,Clusters, Symptom,Symptom Clusters,Syndromes

Related Publications

Christine Lebrun
Radiologically isolated syndrome should be treated with disease-modifying therapy - No.
December 2017, Multiple sclerosis (Houndmills, Basingstoke, England),
Christine Lebrun
Radiologically isolated syndrome should be treated with disease-modifying therapy - Yes.
December 2017, Multiple sclerosis (Houndmills, Basingstoke, England),
Christine Lebrun
Presymptomatic MS or radiologically isolated syndrome should be actively monitored and treated: Commentary.
June 2023, Multiple sclerosis (Houndmills, Basingstoke, England),
Christine Lebrun
Presymptomatic MS or radiologically isolated syndrome (RIS) should be actively monitored and treated - NO.
June 2023, Multiple sclerosis (Houndmills, Basingstoke, England),
Christine Lebrun
Should we treat patients with radiologically isolated syndrome (RIS)? No.
December 2018, Revue neurologique,
Christine Lebrun
Should we treat patients with radiologically isolated syndrome (RIS)? Yes.
December 2018, Revue neurologique,
Christine Lebrun
Quality of life should be the primary outcome for disease-modifying therapy trials in MS: Commentary.
August 2023, Multiple sclerosis (Houndmills, Basingstoke, England),
Christine Lebrun
Disease-modifying therapies should be stopped in NMOSD patients in remission - Commentary.
August 2019, Multiple sclerosis (Houndmills, Basingstoke, England),
Christine Lebrun
[Radiologically isolated syndrome].
January 2009, Revista de neurologia,
Christine Lebrun
Patients with Hepatorenal Syndrome Should Be Dialyzed? COMMENTARY.
March 2021, Kidney360,
Copied contents to your clipboard!